Journal of Pharmacy and Pharmaceutical Research Open Access

  • Journal h-index: 3
  • Journal CiteScore: 0.94
  • Journal Impact Factor: 0.52
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Opinion - (2023) Volume 7, Issue 2

Unraveling the Mechanisms of Drug Action in Tranquilizers: Promoting Calmness and Mental Well-being
Erdem Hande*
Department of Pharmaceutics, University of Melbourne, Australia
*Correspondence: Erdem Hande, Department of Pharmaceutics, University of Melbourne, Australia, Email:

Received: 31-May-2023, Manuscript No. IPIPR-23-16993; Editor assigned: 02-Jun-2023, Pre QC No. IPIPR-23-16993 (PQ); Reviewed: 16-Jun-2023, QC No. IPIPR-23-16993; Revised: 21-Jun-2023, Manuscript No. IPIPR-23-16993 (R); Published: 28-Jun-2023, DOI: 10.21767/ipipr.7.02.015


Tranquilizers, also known as anxiolytics or anti-anxiety medications, are pharmacological agents prescribed to alleviate symptoms of anxiety and promote a sense of calmness and relaxation. These medications play a crucial role in the treatment of anxiety disorders, insomnia, and certain neurological conditions. Understanding the mechanisms of drug action involved in tranquilizers is essential in optimizing their use and improving the well-being of individuals struggling with anxiety. In this article, we delve into the intricacies of tranquilizer pharmacology, exploring how these medications exert their therapeutic effects. The primary mechanism of action for most tranquilizers is modulation of the gamma- aminobutyric acid system, which is the major inhibitory neurotransmitter in the central nervous system.


GABA works by binding to GABA receptors and enhancing inhibitory activity, which counteracts the excessive neuronal firing associated with anxiety. Tranquilizers enhance the effect of GABA by increasing its release or binding affinity to GABA receptors. This promotes inhibitory activity, reducing the excitability of neurons in anxiety-related brain regions, such as the amygdala and prefrontal cortex. Tranquilizers, particularly benzodiazepines, bind to specific sites on GABA receptors, known as benzodiazepine binding sites, thereby enhancing the effects of GABA. This binding facilitates the opening of chloride channels, which leads to hyperpolarization of neurons, making them less likely to generate action potentials and reducing anxiety-related neuronal activity.

Tranquilizers can be classified into several groups based on their pharmacological properties and modes of action. The main classes include benzodiazepines, selective serotonin reuptake inhibitors, and other miscellaneous tranquilizers. Benzodiazepines, such as diazepam, lorazepam, and alprazolam, are the most commonly prescribed tranquilizers. They bind to GABA-A receptors and enhance GABA-mediated inhibitory neurotransmission. Benzodiazepines have a rapid onset of action, making them effective for acute anxiety relief. However, they also carry the risk of dependence and sedation with prolonged use.

Miscellaneous tranquilizers include medications such as buspirone, hydroxyzine, and pregabalin. These agents exert their anxiolytic effects through various mechanisms, including interactions with serotonin, dopamine, and GABA receptors. Their modes of action are often distinct from benzodiazepines and SSRIs, providing alternative treatment options for individuals who may not respond to or tolerate these medications. The selection of a tranquilizer and dosing regimen depends on various factors, including the type and severity of anxiety, comorbid conditions, and individual patient characteristics.


Tranquilizers are valuable tools in the management of anxiety disorders, offering relief from distressing symptoms and promoting mental well-being. By understanding the mechanisms of drug action in tranquilizers, healthcare professionals can make informed decisions when prescribing these medications, considering individual patient characteristics, treatment goals, and potential risks. Personalized treatment approaches, including the selection of appropriate tranquilizers and combination therapies, are essential in optimizing outcomes and supporting individuals on their journey towards anxiety control and improved quality of life. Continued research and advancements in tranquilizer pharmacology hold promise for the development of novel medications and therapeutic strategies that further enhance the treatment of anxiety disorders.

Citation: Hande E (2023) Unraveling the Mechanisms of Drug Action in Tranquilizers: Promoting Calmness and Mental Well-being. J Pharm Pharm Res. 7:015

Copyright: © 2023 Hande E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Awards Nomination 0.329+ Million Readerbase
Share This Page
Recommended Webinars & Conferences

11th International Conference on Clinical Trials

London, UK